
STAAR Surgical Company – NASDAQ:STAA
STAAR Surgical Company stock price today
STAAR Surgical Company stock price monthly change
STAAR Surgical Company stock price quarterly change
STAAR Surgical Company stock price yearly change
STAAR Surgical Company key metrics
Market Cap | 1.18B |
Enterprise value | 3.08B |
P/E | 82.92 |
EV/Sales | 10.85 |
EV/EBITDA | 58.81 |
Price/Sales | 11.05 |
Price/Book | 9.46 |
PEG ratio | 1.48 |
EPS | 0.32 |
Revenue | 326.24M |
EBITDA | 31.68M |
Income | 15.29M |
Revenue Q/Q | 5.20% |
Revenue Y/Y | 10.69% |
Profit margin | 13.63% |
Oper. margin | 15.4% |
Gross margin | 78.55% |
EBIT margin | 15.4% |
EBITDA margin | 9.71% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSTAAR Surgical Company stock price history
STAAR Surgical Company stock forecast
STAAR Surgical Company financial statements
Jun 2023 | 92.30M | 6.06M | 6.57% |
---|---|---|---|
Sep 2023 | 80.30M | 4.81M | 6% |
Dec 2023 | 76.27M | 7.75M | 10.17% |
Mar 2024 | 77.35M | -3.33M | -4.32% |
Mar 2024 | 77.35M | -3.33M | -4.32% |
---|---|---|---|
Sep 2025 | 102.74M | 13.12M | 12.77% |
Sep 2025 | 101.77M | 11.25M | 11.06% |
Dec 2025 | 92.98M | 7.62M | 8.2% |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 440651000 | 86.95M | 19.73% |
---|---|---|---|
Sep 2023 | 471521000 | 92.92M | 19.71% |
Dec 2023 | 488692000 | 102.73M | 21.02% |
Mar 2024 | 492535000 | 99.74M | 20.25% |
Jun 2023 | -6.30M | 10.17M | 1.30M |
---|---|---|---|
Sep 2023 | -5.97M | 31.84M | 7.10M |
Dec 2023 | 31.96M | 22.40M | 367K |
Mar 2024 | 21.68M | 16.18M | 4.05M |
STAAR Surgical Company alternative data
Aug 2023 | 882 |
---|---|
Sep 2023 | 882 |
Oct 2023 | 882 |
Nov 2023 | 882 |
Dec 2023 | 882 |
Jan 2024 | 882 |
Feb 2024 | 882 |
Mar 2024 | 1,056 |
Apr 2024 | 1,056 |
May 2024 | 1,056 |
Jun 2024 | 1,056 |
Jul 2024 | 1,056 |
STAAR Surgical Company other data
Period | Buy | Sel |
---|---|---|
Jan 2024 | 230595 | 0 |
Mar 2024 | 1750 | 0 |
May 2024 | 1 | 0 |
Aug 2024 | 1315 | 0 |
Dec 2024 | 80200 | 0 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Purchase | BROADWOOD PARTNERS, L.P. 10 percent owner | Common Stock | 23,000 | $12.16 | $279,749 | ||
Purchase | BROADWOOD PARTNERS, L.P. 10 percent owner | Common Stock | 3,700 | $12.29 | $45,480 | ||
Purchase | BROADWOOD PARTNERS, L.P. 10 percent owner | Common Stock | 7,280 | $12.42 | $90,381 | ||
Purchase | BROADWOOD PARTNERS, L.P. 10 percent owner | Common Stock | 46,220 | $12.08 | $558,153 | ||
Purchase | BUTCHER ARTHUR C director | Common Stock | 1,315 | $37.99 | $49,957 | ||
Purchase | BROADWOOD PARTNERS, L.P. 10 percent owner | Common Stock | 1 | $21.28 | $21 | ||
Purchase | WEISNER AIMEE S director | Common Stock | 1,750 | $38.11 | $66,693 | ||
Option | WILLIAMS PATRICK F. officer: Chief Fi.. | Common Stock | 2,614 | N/A | N/A | ||
Purchase | BROADWOOD PARTNERS, L.P. 10 percent owner | Common Stock | 4,042 | $13.55 | $54,785 | ||
Purchase | BROADWOOD PARTNERS, L.P. 10 percent owner | Common Stock | 100 | $14.45 | $1,445 |
Patent |
---|
Grant Filling date: 8 Mar 2017 Issue date: 5 Jan 2021 |
Grant Filling date: 19 Aug 2019 Issue date: 15 Sep 2020 |
Grant Filling date: 8 Sep 2015 Issue date: 26 Nov 2019 |
Quarter | Transcript |
---|---|
Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 26 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 1 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 2 Aug 2023 | Q2 2023 Earnings Call Transcript |
STAAR Surgical: Not In My Sight Yet
STAAR Surgical: Economic Realities Beginning To Surface, Reiterate Hold
Sight Sciences: Recent Stock Price Pullback Is Unwarranted
I See Opportunity In STAAR Surgical
STAAR Surgical: A Good Business That (Almost) Anyone Can Run
STAAR Surgical Company: Getting Ahead Of Itself In 2023
STAAR Surgical: Reasonable Risk-Reward For A High-Growth Company
Keep Adding To STAAR Surgical Longs, Buy Thesis Remains
STAAR Surgical: Hard Data Approach Justifies Long-Only Portfolio Allocation
-
What's the price of STAAR Surgical Company stock today?
One share of STAAR Surgical Company stock can currently be purchased for approximately $28.02.
-
When is STAAR Surgical Company's next earnings date?
Unfortunately, STAAR Surgical Company's (STAA) next earnings date is currently unknown.
-
Does STAAR Surgical Company pay dividends?
No, STAAR Surgical Company does not pay dividends.
-
How much money does STAAR Surgical Company make?
STAAR Surgical Company has a market capitalization of 1.18B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 13.37% to 322.42M US dollars.
-
What is STAAR Surgical Company's stock symbol?
STAAR Surgical Company is traded on the NASDAQ under the ticker symbol "STAA".
-
What is STAAR Surgical Company's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of STAAR Surgical Company?
Shares of STAAR Surgical Company can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are STAAR Surgical Company's key executives?
STAAR Surgical Company's management team includes the following people:
- Ms. Caren L. Mason Chief Executive Officer, Pres & Director(age: 71, pay: $1,060,000)
- Dr. Scott D. Barnes M.D. Chief Medical Officer(age: 62, pay: $627,250)
- Mr. Hans-Martin Blickensdoerfer Senior Vice President of Commercial Operations and Director of Markets - Europe & China(age: 60, pay: $551,590)
- Dr. Keith Holliday Chief Technology Officer(age: 62, pay: $544,820)
- Mr. Patrick F. Williams Chief Financial Officer(age: 52, pay: $449,770)
-
How many employees does STAAR Surgical Company have?
As Jul 2024, STAAR Surgical Company employs 1,056 workers.
-
When STAAR Surgical Company went public?
STAAR Surgical Company is publicly traded company for more then 33 years since IPO on 24 Feb 1992.
-
What is STAAR Surgical Company's official website?
The official website for STAAR Surgical Company is staar.com.
-
Where are STAAR Surgical Company's headquarters?
STAAR Surgical Company is headquartered at 25651 Atlantic Ocean Drive, Lake Forest, CA.
-
How can i contact STAAR Surgical Company?
STAAR Surgical Company's mailing address is 25651 Atlantic Ocean Drive, Lake Forest, CA and company can be reached via phone at +62 630 37902.
STAAR Surgical Company company profile:

STAAR Surgical Company
staar.comNASDAQ
1,056
Medical - Instruments & Supplies
Healthcare
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Lake Forest, CA 92630
CIK: 0000718937
ISIN: US8523123052
CUSIP: 852312305